Abbott's Q3 Earnings Meet Estimates, Revenues Up Y/Y, Stock Climbs
Key Takeaways Abbott posted Q3 adjusted EPS of $1.30, matching estimates and rising 7.4% year over year.ABT's Q3 sales grew 6.9% to $11.37B, led by strong growth in the Medical Devices and Nutrition units.Abbott's full-year EPS guidance was reaffirmed at $5.12$5.18, with organic sales growth of 7.5%8%.Abbott Laboratories (ABT) reported third-quarter 2025 adjusted earnings per share (EPS) of $1.30, which came in line with the Zacks Consensus Estimate. The figure improved 7.4% from the prior-year quarter’s le ...